Buy or sell Compass Pathways stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Compass Pathways Stock

Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.

About Compass Pathways Stock

Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.

Funding History

January 2017$4.0M

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Compass Pathways or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo